Long Term Follow-Up Study of a Randomized, Open-Label, Uncontrolled, Phase I/II Study to Assess the Safety and Immunogenicity of Intramuscular and Intradermal Doses of COVID-19 DNA Vaccine (AG0302-COVID19)

Pharmacological studies have demonstrated antibody production and infection prevention with an intradermal coronavirus disease 2019 (COVID-19) DNA vaccine (AG0302-COVID-19). This clinical trial aimed to investigate the safety and immunogenicity of high doses of AG0302-COVID19 when injected intramusc...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakagami, Hironori, Matsumoto, Tetsuya, Takazawa, Kenji, Sekino, Hisakuni, Matsuoka, Osamu, Inoue, Satoshi, Furuie, Hidetoshi, Morishita, Ryuichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611071/
https://www.ncbi.nlm.nih.gov/pubmed/37896939
http://dx.doi.org/10.3390/vaccines11101535

Ejemplares similares

Ejemplares similares